COVID-19 Impact on GlaxoSmithKline

COVID-19 Impact on GlaxoSmithKline

Summary

"COVID-19 Impact on GlaxoSmithKline" reports key findings as of 3rd February, 2021 based on market analysis and brand diversification by industry and geography.

Both OTC healthcare and cosmetics and toiletries industries are forecast to grow during 2020-2025, presenting ample opportunities for the company to increase its sales. Particularly, GSK’s consumer goods business focus is healthcare, and this area has benefited from the pandemic as consumers have been becoming health-attentive. Understandably, the company is well-positioned amid as well as after the health crisis.

Scope

• GSK has strong product diversification that is aligned with changing consumer demands after the pandemic
• Despite the impact of COVID-19, both cosmetics and toiletries and OTC healthcare industries are likely to grow across the regions
• The COVID-19 pandemic has had a significant impact on industries, such as alcoholic drinks and some categories under cosmetics and toiletries. However, all industries show a positive outlook during 2020-2025, and severely impacted categories are expected to bounce back
• The cosmetics and toiletries industry is expected to present more growth opportunities to GSK

Reasons to Buy

• Understand the challenges and opportunities for a specific company in order to tap into what is really impacting the industry.
• Gain a broader appreciation of the fast-moving consumer goods industry by gaining insights from both within and outside of your sector.
• Access valuable strategic take-outs to help direct future decision-making and inform new product development.